OMERS Administration Corp’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5M Buy
21,073
+2,276
+12% +$1.01M 0.06% 190
2026
Q1
$8.39M Buy
18,797
+3,318
+21% +$1.55M 0.05% 161
2025
Q4
$7.02M Buy
15,479
+1,725
+13% +$744K 0.05% 151
2025
Q3
$5.39M Hold
13,754
0.04% 177
2025
Q2
$6.12M Buy
13,754
+100
+0.7% +$46.1K 0.05% 144
2025
Q1
$6.62M Sell
13,654
-88
-0.6% -$41K 0.06% 137
2024
Q4
$5.53M Sell
13,742
-1,213
-8% -$562K 0.05% 148
2024
Q3
$6.96M Buy
14,955
+400
+3% +$192K 0.06% 131
2024
Q2
$6.82M Buy
+14,555
New +$6.32M 0.07% 135

Other funds holding VRTX

OMERS Administration Corp's VRTX Position: Q2 2026 in Review

OMERS Administration Corp increased its Vertex Pharmaceuticals (VRTX) stake by 12% in Q2 2026, buying an estimated $1.01M and bringing the position to 21,073 shares worth $10.5M. The position accounts for 0.06% of the portfolio, ranked #190.

OMERS Administration Corp first reported a position in VRTX in Q2 2024 and has held it in 9 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • OMERS Administration Corp held 21,073 shares of Vertex Pharmaceuticals worth $10.5M as of Q2 2026.
  • OMERS Administration Corp bought 2,276 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.01M.
  • Vertex Pharmaceuticals made up 0.06% of OMERS Administration Corp's portfolio in Q2 2026, its #190 holding.
  • OMERS Administration Corp first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.